Fresenius Kabi
Kai Dins currently serves as the Global CRM & Application Lead (Director) at Fresenius Kabi since March 2024. Prior to this role, Kai Dins held various positions at Merck Group from September 2008 to February 2024, including Head of CRM & Commercial Tools for Science & Lab Solutions in the EMEA region. Responsibilities encompassed leading CRM and pricing-related projects, training, and user support across multiple roles. Kai Dins also managed global CRM system rollouts and provided commercial support in the ASPAC region. Educational qualifications include a Bachelor's Degree in Business Administration from Fachhochschule Darmstadt and training at Kombrecht-Engel-Schule in collaboration with Merck KGaA.
This person is not in any offices
Fresenius Kabi
15 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.